Impact of microsatellite status on chemotherapy for colorectal cancer patients with KRAS or BRAF mutation.

MLA

Chi-Jung Huang, et al. “Impact of Microsatellite Status on Chemotherapy for Colorectal Cancer Patients with KRAS or BRAF Mutation.” Oncology Letters, vol. 12, no. 6, Dec. 2016, pp. 4427–34. EBSCOhost, https://doi.org/10.3892/ol.2016.5275.

APA

Chi-Jung Huang, Shih-Hung Huang, Chih-Cheng Chien, Henry Hsin-Chung Lee, Shung-Haur Yang, Chun-Chao Chang, & Chia-Long Lee. (2016). Impact of microsatellite status on chemotherapy for colorectal cancer patients with KRAS or BRAF mutation. Oncology Letters, 12(6), 4427–4434. https://doi.org/10.3892/ol.2016.5275

Chicago

Chi-Jung Huang, Shih-Hung Huang, Chih-Cheng Chien, Henry Hsin-Chung Lee, Shung-Haur Yang, Chun-Chao Chang, and Chia-Long Lee. 2016. “Impact of Microsatellite Status on Chemotherapy for Colorectal Cancer Patients with KRAS or BRAF Mutation.” Oncology Letters 12 (6): 4427–34. doi:10.3892/ol.2016.5275.